Get started Log in

AGY — Allergy Therapeutics Share News

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Market Cap
£300.80m
Enterprise Value
£317.46m
Revenue
£55.04m

Allergy Therapeutics - Holding(s) in Company
28/11/2023 15:03
Allergy Therapeutics - Director/PCA Dealing
10/11/2023 13:22
Allergy Therapeutics - Holding(s) in Company
10/11/2023 13:11
ZQ Capital Limited Allergy Therapeutics - Offer Closure
10/11/2023 07:00
Allergy Therapeutics - Update on funding
06/11/2023 07:00
Allergy Therapeutics - Holding(s) in Company
20/10/2023 17:17
Brief: Allergy Therapeutics Reports Unconditional Mandatory Cash Offer For Allergy Therapeutics Plc By Skygem Acquisition Limited
19/10/2023 07:21
ZQ Capital Limited Allergy Therapeutics - Posting of Offer Document
19/10/2023 07:00
Allergy Therapeutics - Holding(s) in Company
16/10/2023 15:03
ZQ Capital Limited Allergy Therapeutics - Unconditional Mandatory Cash Offer
16/10/2023 08:01
Brief: Allergy Therapeutics Raises Gross Proceeds Of About £40.75 Mln Via Equity Financing
13/10/2023 07:18
Allergy Therapeutics - Result of Open Offer and Subscription
13/10/2023 07:00
Brief: Allergy Therapeutics FY Revenue Fell 16% To 61.0 Million Stg
27/09/2023 07:32
Allergy Therapeutics - Unaudited Preliminary Results 2023
27/09/2023 07:00
Brief: Allergy Therapeutics's Phase I VLP Peanut Protect Trial Progress
26/09/2023 07:26
Brief: Allergy Therapeutics Announces Satisfaction Of FDI Clearance Conditions
22/09/2023 07:29
UK's Allergy Therapeutics falls on funding woes, poor sales outlook
10/08/2023 08:41
Brief: Allergy Therapeutics PLC Says FY Rev Expected To Be 16% Lower At £61.0 Million
10/08/2023 07:42
Allergy Therapeutics - Trading update for the year ended 30 June 2023
10/08/2023 07:00
Brief: Allergy Therapeutics Appoints Shaun Furlong As Chief Financial Officer
10/07/2023 13:32